New Paradigms in the Prevention and Treatment of Migraine with HT1F Agonist and mAb Against CGRP Pathway or its Receptor
CME | CNE 1.00 Credit
Program Description
This webcast is intended to improve care of patients with migraine by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Intended Audience
This webcast is designed to meet the educational needs of neurologists, internal medicine, family medicine physicians, nurse practitioners, physician assistants, nurses and allied healthcare professionals involved in the diagnosis and treatment of patients with migraine.
Commercial Supporters
Supported by Amgen and Alder Biopharmaceuticals, Inc.